memantine

is in a different class than other approved Alzheimer's drugs, which are all cholinesterase inhibitors; memantine, marketed as Namenda, is an NMDA (N-methyl-D-aspartate) receptor antagonist.

There is currently no content classified with this term.

Subscribe to RSS - memantine